(Q44951983)
Statements
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments (English)
Katherine S Panageas
Chau T Dang
Andrew J Dannenberg
Kotha Subbaramaiah
Maura N Dickler
Mark M Moasser
Andrew D Seidman
Maria Theodoulou
Clifford A Hudis